Detalhe da pesquisa
1.
Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Circ Res
; 132(5): 545-564, 2023 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744494
2.
Single-Cell Imaging Maps Inflammatory Cell Subsets to Pulmonary Arterial Hypertension Vasculopathy.
Am J Respir Crit Care Med
; 209(2): 206-218, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934691
3.
PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
Circ Res
; 128(3): 401-418, 2021 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33322916
4.
Time-Dependent Factors Influencing Cardiocerebral Vascular Events in Chronic Hemodialysis Patients: Insights from a Longitudinal Study.
Med Sci Monit
; 29: e941553, 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846048
5.
Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 206(8): 1019-1034, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696338
6.
Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.
Circ Res
; 124(2): 211-224, 2019 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30582451
7.
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
Circulation
; 140(17): 1409-1425, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462075
8.
The Phosphate Fast-Responsive Genes PECP1 and PPsPase1 Affect Phosphocholine and Phosphoethanolamine Content.
Plant Physiol
; 176(4): 2943-2962, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29475899
9.
Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
Circulation
; 136(20): 1920-1935, 2017 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935667
10.
Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-ß in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol
; 37(8): 1559-1569, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619995
11.
Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.
Am J Respir Crit Care Med
; 195(7): 930-941, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27779452
12.
In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.
Circulation
; 133(18): 1783-94, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27045138
13.
Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathway.
J Biol Chem
; 290(7): 4047-58, 2015 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540198
14.
Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.
Am J Respir Crit Care Med
; 191(11): 1273-86, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25853696
15.
RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 192(3): 356-66, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26030479
16.
Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension.
Am J Respir Crit Care Med
; 189(10): 1260-72, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24702692
17.
High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension.
bioRxiv
; 2024 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352544
18.
Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.
Nat Commun
; 14(1): 7578, 2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989727
19.
Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells.
J Lipid Res
; 52(3): 518-30, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21196532
20.
Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
J Biol Chem
; 285(22): 16664-74, 2010 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20308079